COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 195 filers reported holding COHERUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $782,034 | +2.1% | 209,100 | +16.6% | 0.00% | 0.0% |
| Q2 2023 | $765,611 | -16.7% | 179,300 | +33.5% | 0.00% | 0.0% |
| Q1 2023 | $918,612 | -22.8% | 134,300 | -10.6% | 0.00% | 0.0% |
| Q4 2022 | $1,189,584 | -15.8% | 150,200 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $1,412,000 | +34.3% | 146,900 | +1.2% | 0.00% | 0.0% |
| Q2 2022 | $1,051,000 | -43.9% | 145,200 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,875,000 | -12.3% | 145,200 | +8.4% | 0.00% | 0.0% |
| Q4 2021 | $2,137,000 | -0.7% | 133,900 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,152,000 | +21.2% | 133,900 | +4.3% | 0.00% | 0.0% |
| Q2 2021 | $1,776,000 | -7.7% | 128,400 | -2.5% | 0.00% | 0.0% |
| Q1 2021 | $1,924,000 | -13.9% | 131,700 | +2.4% | 0.00% | -50.0% |
| Q4 2020 | $2,235,000 | -5.3% | 128,600 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,359,000 | +5.5% | 128,600 | +2.7% | 0.00% | 0.0% |
| Q2 2020 | $2,236,000 | +35.2% | 125,200 | +22.7% | 0.00% | 0.0% |
| Q1 2020 | $1,654,000 | -8.2% | 102,000 | +1.9% | 0.00% | 0.0% |
| Q4 2019 | $1,802,000 | -8.9% | 100,100 | +2.5% | 0.00% | 0.0% |
| Q3 2019 | $1,979,000 | -5.6% | 97,700 | +3.0% | 0.00% | 0.0% |
| Q2 2019 | $2,097,000 | +90.8% | 94,900 | +17.7% | 0.00% | +100.0% |
| Q1 2019 | $1,099,000 | +55.7% | 80,600 | +3.3% | 0.00% | 0.0% |
| Q4 2018 | $706,000 | -42.3% | 78,000 | +5.3% | 0.00% | 0.0% |
| Q3 2018 | $1,223,000 | +23.9% | 74,100 | +5.1% | 0.00% | 0.0% |
| Q2 2018 | $987,000 | +36.3% | 70,500 | +7.6% | 0.00% | 0.0% |
| Q1 2018 | $724,000 | +42.5% | 65,500 | +13.5% | 0.00% | 0.0% |
| Q4 2017 | $508,000 | -27.1% | 57,700 | +10.5% | 0.00% | 0.0% |
| Q3 2017 | $697,000 | -6.9% | 52,200 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $749,000 | -32.2% | 52,200 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,104,000 | +5.1% | 52,200 | +39.9% | 0.00% | -50.0% |
| Q4 2016 | $1,050,000 | +5.1% | 37,300 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $999,000 | +58.6% | 37,300 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $630,000 | +6.6% | 37,300 | +29.5% | 0.00% | 0.0% |
| Q1 2016 | $591,000 | +9.4% | 28,800 | +22.6% | 0.00% | 0.0% |
| Q4 2015 | $540,000 | +50.4% | 23,500 | +31.3% | 0.00% | 0.0% |
| Q3 2015 | $359,000 | +51.5% | 17,900 | +118.3% | 0.00% | 0.0% |
| Q2 2015 | $237,000 | – | 8,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |